The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
Expands manufacturing push & locks in major growth deals
The company posted revenue of €1,267 million, up 6% on a constant currency basis
Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights
Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
Subscribe To Our Newsletter & Stay Updated
